Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitors
US9067893B2 · kind B2 · utility
2Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2014 |
| Grant date | Jun 30, 2015 |
| Priority date | — |
| Expiry date | Apr 28, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.